We determined the level of susceptibility of Trypanosoma brucei brucei to the aminoglycoside G418 in vivo and demonstrated that it is possible to select for G418-resistant transfected T. brucei brucei bloodstream parasites in a mouse host by inoculating the drug intraperitoneally at doses between 40 and 80 mg/kg of body weight daily for 3 days. The ability to select for transfectants in vivo offers new possibilities for studies on genetic recombination in these parasites.
genetic recombination in these parasites.
Recent advances in molecular biological techniques to examine Trypanosoma brucei brucei now allow for the genetic manipulation of these parasites by transfection techniques (6, 10, 11, 14) . All reports to date on the stable transformation of these parasites have utilized in vitrogenerated procyclic forms, a stage in the life cycle which occurs in the tsetse fly, the insect vector, and which is noninfective for mammalian hosts (15) . Transfectants have been selected in vitro on the basis of resistance to aminoglycoside antibiotics, principally G418 (Geneticin), resulting from integration by homologous recombination of a T. brucei brucei gene containing the bacterial neo gene, encoding neomycin phosphotransferase II (NPTII) (6, 10, 14) . Although transfection of procyclic cultured forms facilitates new approaches in studies on gene regulation in this lifecycle stage, many of the more desirable and informative studies, involving the life-cycle stage occurring ih the mammalian host, require bloodstream-form transfectants. A recent report by Carruthers and Cross, however, describes a powerful system for high-efficiency clonal growth and selection of stable bloodstream-and procyclic-form transfectants on agarose plates (3a) . In a manner similar to those involving procyclic trypanosomes, techniques for selection of bloodstream-form transfectants at present require growth and selection of this life-cycle stage in in vitro cultivation systems (3a) . Thus, the parasites need to be preadapted to such systems. In vitro cultivation of bloodstream forms, however, is more difficult than that of procyclic forms, and the numbers of bloodstream-form parasites that can be propagated in such systems are considerably lower than the numbers of procyclic forms (2, 3, 8) . It would therefore be useful to be able to select for bloodstream-form transfectants in vivo, particularly since most populations of T. brucei brucei grow well in rodents. Thus, to extend the use of T. brucei brmcei transfection systems for both functional studies on bloodstream forms and studies on sexual recombination in which recombinants contain selectable markers from both parental populations, we tested whether it is possible to select in vivo for transfectants which are resistant to G418.
In this study, we utilized the pleomorphic parasite T. brucei brucei GUTat 3.1, which has the capacity to undergo cyclical development (12) . Bloodstream trypanosomes were transformed in vitro to procyclic forms as described previously (3, 7) , and cultures were maintained for 2 months prior to their use for transfection experiments. Procyclic trypanosomes were then grown to between the mid and late log phase 75 X 106 to 8 x 106/ml), harvested, and resuspended at 5 x 10 /ml in bicine-buffered saline containing 2% (wt/vol) glucose (1). The 3-tubulin gene-targeting plasmid, pUCTbneo3 (14) , digested with the restriction enzymes SacI and SalI to release the T. brucei brucei ,B-tubulin fragment which contains the bacterial neo gene, was added at a final concentration of 8 ,ug/ml, and the mixture was incubated for 10 min at room temperature. The trypanosome-DNA mixture (0.8 ml) was then transferred to a 0.4-cm Bio-Rad electroporation cuvette and subjected to two 300-V pulses at 960 ,uF capacitance, using a Bio-Rad gene pulser with a capacitance extender. The mixture was maintained at room temperature for a further 10 min before being transferred to procyclic culture medium (7) at a concentration of 2 x 106 living trypanosomes per ml. Following an overnight incubation at 27°C, transfected trypanosomes were selected by transferring the electroporated parasites to fresh procyclic culture medium containing G418 at a concentration of 25 ,ug/ml, with a cell density of 2 x 106 viable trypanosomes per ml. After 4 days of incubation in this concentration of G418, no dividing trypanosomes could be detected by microscopic examination, and by day 7, the majority of trypanosomes were dead. Cultures were then diluted by 10Ox and 1,000x in 24-well tissue culture plates containing 1 ml of medium (plus 25 ,ug of G418 per ml) in each well. The cultures were then maintained at 27°C in a humidified atmosphere of 5% CO2 in air and monitored for the next 7 days. Trypanosomes from culture wells found to contain actively dividing trypanosomes were then transferred to larger-volume cultures, expanded separately, and subsequently analyzed. Each expanded population was designated GUTat 3.1/BBR1 to -22. On the basis of the number of wells containing G418-resistant trypanosomes, the generation frequency of stable transfectants was estimated to be approximately 1 to 2 in 105 trypanosomes.
To establish that the G418-resistant trypanosomes arose through integration of the neo gene into the T. brucei brucei tubulin gene cluster, parasites from the expanded cultures were harvested and embedded in 0.7% low-melting-point agarose and prepared for pulsed-field gel electrophoresis as described previously (16 (9) and isolation of the trypanosome DNA (Fig. 1E) .
To characterize the sensitivity of the trypanosome popu- To determine the levels of resistance of bloodstream-form transfectants to G418, it was necessary to transfect procyclic cultured forms and select for mammalian infective forms from these cultures. The clear differences in the levels of resistance in vivo between the transfectant, GUTat 3.1/ BBR3, analyzed in this study and the parental population, GUTat 3.1, demonstrated that it should be possible to directly select for transfectants in mice. Information on the levels of resistance of bloodstream-form T. brucei brucei transfectants to G418 could now be utilized in the development of efficient stable transfection techniques for bloodstream parasites. Such a selection system would be beneficial in circumstances in which it is not possible to utilize an in vitro selection system and would also overcome the requirement for the parasites to be preadapted to in vitro culture systems prior to transfection. This would thus broaden the numbers of parasite isolates which could be used in transfection experiments. Furthermore, the ability to select for transfectants of T. brucei brucei in vivo also offers new possibilities for studies on genetic recombination in these parasites. Since the present transfection techniques facilitate targeting of foreign genes to specific loci, genetic crosses between, for example, trypanocide-resistant field isolates and laboratory-generated transfected G418-resistant parasites should now be possible. Such selection for recombinants would therefore offer new possibilities in studies on the genetics of these organisms.
Finally, we were somewhat surprised at the potency of G418 against T. brucei brucei in vivo; even at high levels of parasitemia, nearly all the parasites disappeared from the bloodstream within 24 h following the first drug treatment at 40 mg/kg of bw (llb). Furthermore, by comparison with other organisms (5), bloodstream-form T. brucei brucei parasites are extremely sensitive to G418 and show a significantly greater level of sensitivity (approximately 100-fold) to G418 in vitro compared with procyclic forms (lla). The reasons for the differing sensitivities of the two life-cycle stages of T. brucei brucei to G418 may be related to differences in growth rates or differences in their rates of endocytosis (17) . Other salivarian trypanosomes such as T. congolense are as sensitive to G418 in vivo as T. brucei brucei (llb). The reasons for the relatively high levels of sensitivity of trypanosomes to G418 in comparison to other eukaryotes are unclear, but since G418 is an aminoglycoside, it may be related to the unusual structure of their ribosomes (18) . This possibility should be investigated further since it may present some potential for the generation and testing of potent inhibitors of trypanosome ribosome function, with minimal inhibition of host function, thus offering new prospects for the control of trypanosomes and the treatment of the disease in the future.
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